John Hohneker - 01 Apr 2024 Form 4 Insider Report for Carisma Therapeutics Inc. (CARM)

Role
Director
Signature
/s/ Eric Siegel, as Attorney-in-Fact for John Hohneker
Issuer symbol
CARM
Transactions as of
01 Apr 2024
Net transactions value
$0
Form type
4
Filing time
01 Apr 2024, 18:59:39 UTC
Previous filing
12 Jun 2023
Next filing
20 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CARM Stock Option (Right to Buy) Award $0 +38,700 $0.000000 38,700 01 Apr 2024 Common Stock 38,700 $2.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest over three years in equal monthly installments following April 1, 2024, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.